PFDN6
Prefoldin subunit 6
Also known as: H2-KE2, HKE2, KE-2, PFD6, PFD6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15212
- Gene
- PFDN6
- Ensembl
- ENSG00000204220
- Chromosome
- 6
- Canonical length
- 129 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Cytosol
OverviewNCBI Gene
PFDN6 is a subunit of the heteromeric prefoldin complex that chaperones nascent actin (see MIM 102560) and alpha- and beta-tubulin (see MIM 602529 and MIM 191130, respectively) chains pending their transfer to the cytosolic chaperonin containing TCP1 (MIM 186980) (CCT) complex (Hansen et al., 1999 [PubMed 10209023]).[supplied by OMIM, Jul 2010]
Canonical amino-acid sequenceUniProt
129 residues, UniProt reviewed canonical sequence.
>O15212|PFDN6
1 MAELIQKKLQ GEVEKYQQLQ KDLSKSMSGR QKLEAQLTEN NIVKEELALL DGSNVVFKLL
61 GPVLVKQELG EARATVGKRL DYITAEIKRY ESQLRDLERQ SEQQRETLAQ LQQEFQRAQA
121 AKAGAPGKALocalizationUniProt · AlphaFold · HPA
Whether an antibody against PFDN6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 124 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 124 nTPM
- amygdala: 120 nTPM
- cerebral cortex: 115 nTPM
- hippocampal formation: 114 nTPM
- hypothalamus: 110 nTPM
- basal ganglia: 102 nTPM
Single-cell type
- oocytes: 244 nCPM
- late primary spermatocytes: 193 nCPM
- early primary spermatocytes: 131 nCPM
- migrating cytotrophoblasts: 105 nCPM
- extravillous trophoblasts: 104 nCPM
- cytotrophoblasts: 99 nCPM
Immune cell
- non-classical monocyte: 3.5 nTPM
- plasmacytoid DC: 3.5 nTPM
- T-reg: 3.5 nTPM
- memory B-cell: 3.3 nTPM
- intermediate monocyte: 3.2 nTPM
- naive B-cell: 3.2 nTPM
Brain region
- cerebral cortex: 12 nTPM
- white matter: 11 nTPM
- pons: 11 nTPM
- midbrain: 10 nTPM
- medulla oblongata: 10 nTPM
- hypothalamus: 9.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.34
- gnomAD pLI
- 0.94
- gnomAD missense Z
- 1.41
- DepMap mean gene effect
- -1.7
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chaperone-mediated protein complex assembly
- negative regulation of amyloid fibril formation
- protein folding
- protein stabilization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PFDN6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PFDN6 as an antibody target. Whether an autoantibody or antibody against PFDN6 could matter depends on whether native PFDN6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PFDN6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PFDN6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...